Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
It represents a new class of therapies called triple agonists, meaning it simultaneously activates three key hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
People taking GLP-1 receptor agonists may become dehydrated from vomiting or diarrhea, causing kidney problems
Use single-use needles and syringes only never share equipment between individuals
Clinical trial data from Eli Lillys Phase 2 study showed that the 12mg weekly dose produced an average weight loss of 24.2% over 48 weeks, with over 80% of participants losing at least 15% of their starting body weight
US$ 22.29
US$ 29.93
US$ 26.05
US$ 26.11
